Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies [NA]
The CBTpro trial, scaling up CBT for psychosis using simulated patients and spoken language technologies, has completed and posted results. …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study [NA]
A completed pilot trial evaluated Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) for individuals with early psyc…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings [NA]
This completed clinical trial compares two behavioral approaches to quitting smoking in individuals with tobacco use disorder and mental hea…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression [NA]
A clinical trial update evaluating deep transcranial magnetic stimulation for bipolar depression, focusing on efficacy, tolerability, and co…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Psychophysiological Responses to Six Single-Session Self-Regulation Interventions in a Female Adult With ADHD and Stabilized Bipolar Disorder [NA]
This ClinicalTrials.gov entry outlines a study of psychophysiological responses to six single-session self-regulation interventions in a fem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Enhanced Coordinated Specialty Care for Early Psychosis [NA]
Clinical trial update indicating recruitment for Enhanced Coordinated Specialty Care for early psychosis at McLean Hospital.
-
EMA approval · 2026-02-25EMA Authorised: Sycrest (asenapine maleate) — Organon N.V.
The EMA authorised Sycrest (asenapine maleate) for the treatment of bipolar disorder. Organon N.V. is the marketing authorisation holder.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: LRFN5 and OLFM4 in Bipolar Disorder
A completed clinical trial evaluating LRFN5 and OLFM4 as biomarkers in Bipolar Disorder.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
This clinical trial update describes a study examining how lithium impacts the brain's functional and structural connectome in treating bipo…
-
FDA approval · 2026-02-25FDA Approved: LAMOTRIGINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' original ANDA for generic lamotrigine.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder
An observational clinical trial update evaluating how oral cariprazine affects disease activity in adults with Bipolar I Disorder.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE) [Phase 4]
A Phase 4 clinical trial from Mayo Clinic is evaluating whether RNA editing can serve as a biomarker to predict antidepressant response in a…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Effectiveness RCT of Customized Adherence Enhancement [NA]
This document notes an effectiveness randomized controlled trial of Customized Adherence Enhancement for Bipolar Disorder. The study is curr…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Psychobiological Markers to Improve Diagnosis and to Predict Affective Episodes in Bipolar Disorder
Karolinska Institutet is conducting a trial to identify psychobiological markers to improve diagnosis and predict affective episodes in bipo…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
This clinical trial update describes a retrospective observational study evaluating blood-based biomarkers for diagnosing and monitoring sev…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II. [Phase 3]
A Phase 3 clinical trial evaluating the efficacy, safety, and tolerability of lacosamide for major depressive episodes in Bipolar I and II d…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Epidemiological Study on the Prevalence of Mental Disorders in Slovakia
A completed epidemiological study from Comenius University assessing the prevalence of several mental disorders in Slovakia.
-
FDA approval · 2026-02-18FDA Approved: ARIPIPRAZOLE — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for aripiprazole from Aurobindo Pharma Limited, providing a generic version of the antipsychotic. The approva…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Clocks in Sync - Circadian Rhythm and Bipolar Mania [NA]
A completed clinical trial from the Ottawa Hospital Research Institute examining circadian rhythm in bipolar mania.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Greater Houston Area Pediatric Bipolar Registry
Clinical trial registry update for a Greater Houston Area study focused on pediatric bipolar disorder. The trial is currently recruiting par…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects [Phase 3]
This is a Phase 3 long-term safety extension study update for the olanzapine/samidorphan combination (OLZ/SAM) in pediatric subjects with bi…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder [Phase 3]
Phase 3 pediatric trial update from Alkermes evaluating weight gain using BMI z-score in children with schizophrenia or Bipolar I Disorder; …
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression [NA]
This clinical trial aims to develop brain imaging analysis methods to personalize transcranial electrical stimulation for treating anhedonia…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital [NA]
A Massachusetts General Hospital-sponsored clinical trial at Worcester Recovery Center and Hospital is currently recruiting. The study targe…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: TMS for Improving Cognitive Function in Bipolar Disorder [NA]
This clinical trial evaluates transcranial magnetic stimulation for improving cognitive function in people with bipolar disorder and cogniti…